Hronična mijeloidna leukemija (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hronična mijeloidna leukemija" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

4^th place

3^rd place

2^nd place

doi.org

Tefferi A (2006). „Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era”. Hematology Am Soc Hematol Educ Program 2006: 240–245. DOI:10.1182/asheducation-2006.1.240. PMID 17124067.
Jabbour E, Cortes JE, Giles FJ, O'Brien S, Kantarjian HM (2007). „Current and emerging treatment options in chronic myeloid leukemia”. Cancer 109 (11): 2171–2181. DOI:10.1002/cncr.22661. PMID 17431887.
Kimura S, Ashihara E, Maekawa T (2006). „New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia”. Current Pharmaceutical Biotechnology 7 (5): 371–379. DOI:10.2174/138920106778521532. PMID 17076652.

Faderl S, Talpaz M, Estrov Z, Kantarjian HM (1999). „Chronic myelogenous leukemia: biology and therapy”. Annals of Internal Medicine 131 (3): 207–219. PMID 10428738.
Moloney WC (1987). „Radiogenic leukemia revisited”. Blood 70 (4): 905–908. PMID 3477299.
Tefferi A (2006). „Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era”. Hematology Am Soc Hematol Educ Program 2006: 240–245. DOI:10.1182/asheducation-2006.1.240. PMID 17124067.
Jabbour E, Cortes JE, Giles FJ, O'Brien S, Kantarjian HM (2007). „Current and emerging treatment options in chronic myeloid leukemia”. Cancer 109 (11): 2171–2181. DOI:10.1002/cncr.22661. PMID 17431887.
Kimura S, Ashihara E, Maekawa T (2006). „New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia”. Current Pharmaceutical Biotechnology 7 (5): 371–379. DOI:10.2174/138920106778521532. PMID 17076652.